NCT04287829

✓ Unanimous Initial: other Requery: other — This is a cancer treatment study involving intravenous pembrolizumab infusions and oral lenvatinib capsules delivered at an outpatient cancer center/clinic rather than requiring hospital admission. Thinking: other — The intervention involves outpatient IV infusions every 3 weeks and oral medication, indicating delivery in an outpatient clinic rather than requiring hospitalization.

✓ Unanimous Initial: hospital Requery: hospital — The intervention involves intravenous infusions which are typically administered in a hospital setting. Thinking: other — Pembrolizumab infusions and oral lenvatinib are given in an outpatient oncology clinic at a cancer institute, not requiring hospital admission.